Award
Purchase Order #75N98026P01644
Illumina Inc. Secures License and Server Purchase for Biomedical Analysis
Buyer
National Institutes of Health
Award Amount
$95,025.00
Ceiling
$95,025.00
Awarded
September 23, 2026
Period of Performance
Sep 23, 2026 – Sep 22, 2027
Identifier
75N98026P01644
NAICS
334516
This award represents a purchase order contract granted to Illumina, Inc., a leading company specializing in genetic sequencing and analysis technologies. The contract covers the acquisition of an Illumina DRAGEN throughput license along with the DRAGEN Server v4, which are essential products for high-performance genomic data processing and analysis. The significance of this contract lies in enhancing the agency's capabilities in biomedical research and healthcare innovation, contributing to advancements in genetic diagnostics and related fields. The scope involves providing the specialized software license and server hardware that support accelerated and accurate data throughput. This contract was awarded through a competitive process and is slated for a one-year performance period, ensuring timely delivery and integration of the technology at the Bethesda, Maryland site. The award, though of modest financial scale, is critical in supporting ongoing scientific missions requiring cutting-edge genomic analysis tools.
Description
ILLUMINA DRAGEN THROUGHPUT LICENSE AND DRAGEN SERVER V4